Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Allogeneic Anti-Ny-Eso-1-Tcr-Il-15-Transduced Cord Blood-Derived Natural Killer Cells
Plasma Cell Myeloma
M.D. Anderson Cancer Center
P1/2
CC
(45)
Allogeneic Cytomegalovirus-Specific T Cells
Glioblastoma
Queensland Institute of Medical Research
P1/2
CC
(45)
Allogeneic Human Umbilical Cord Blood
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
The First Affiliated Hospital with Nanjing Medical University
P1/2
CC
(45)
Aln-Sod
Amyotrophic Lateral Sclerosis
Regeneron Pharmaceuticals
P1/2
CC
(45)
als20
Beta Thalassemia
Children's Hospital of Philadelphia
P1/2
CC
(45)
Amt-116
Cancer
Multitude Therapeutics Inc.
P1/2
CC
(45)
Amt-253
Cancer
Multitude Therapeutics Inc.
P1/2
CC
(45)
Amt-253 For
Melanoma
Multitude Therapeutics Inc.
P1/2
CC
(45)
Amxt1501
Diffuse Midline Glioma, H3 K27M-Mutant
Aminex Therapeutics, Inc.
P1/2
CC
(45)
Amxt1501
Malignant Glioma
Aminex Therapeutics, Inc.
P1/2
CC
(45)
Amxt1501
Neoplasm
Aminex Therapeutics, Inc.
P1/2
CC
(45)
Amxt 1501 Dicaprate
Cutaneous Melanoma
Aminex Therapeutics, Inc.
P1/2
CC
(45)
Anakinra
Non-Small Cell Lung Carcinoma
Thomas Marron
P1/2
CC
(45)
Anti-Gprc5D Car-T Cells
Plasma Cell Myeloma
XuYan
P1/2
CC
(45)
Anti-Hcd70 Car Transduced Pbl
Renal Cell Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(45)
Anti-Siglec-6 Car-T Cell Therapy
Acute Myeloid Leukemia
Xuzhou Medical University
P1/2
CC
(45)
Apg 115
Acute Myeloid Leukemia
Ascentage Pharma Group Inc.
P1/2
CC
(45)
Apg 115
Liposarcoma
Ascentage Pharma Group Inc.
P1/2
CC
(45)
Aro-Alk7
Type 2 Diabetes Mellitus
Arrowhead Pharmaceuticals
P1/2
CC
(45)
Aro-Mapt-Sc
Early-Onset Autosomal Dominant Alzheimer Disease
Arrowhead Pharmaceuticals
P1/2
CC
(45)
Ashwagandha
Ovarian Cancer
Sham Sunder Kakar
P1/2
CC
(45)
Atezolizumab
Atypical Teratoid Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CC
(45)
Atezolizumab
Bile Duct Cancer
University of Florida
P1/2
CC
(45)
Atezolizumab
Epithelioid Sarcoma
National Cancer Institute (NCI)
P1/2
CC
(45)
Atezolizumab
Fibrolamellar Hepatocellular Carcinoma
St. Jude Children's Research Hospital
P1/2
CC
(45)
Showing 3376 to 3400 of 6,302 assets
Previous
Page 136 of 253
Next
